Difference between revisions of "Saillan-Barreau 2008 J Acquir Immune Defic Syndr"
From Bioblast
Purtschera (talk | contribs) |
|||
| Line 5: | Line 5: | ||
|year=2008 | |year=2008 | ||
|journal=J. Acquir. Immune Defic. Syndr. | |journal=J. Acquir. Immune Defic. Syndr. | ||
|mipnetlab= | |mipnetlab=FR_Toulouse_Casteilla L | ||
}} | }} | ||
{{Labeling | {{Labeling | ||
|instruments=Oxygraph-2k | |||
|topics=Respiration; OXPHOS; ETS Capacity | |topics=Respiration; OXPHOS; ETS Capacity | ||
}} | }} | ||
Revision as of 10:11, 12 August 2011
| Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Pénicaud L (2008) Drug-specific effect of nelfinavir and stavudine on primary culture of human preadipocytes. J. Acquir. Immune Defic. Syndr. 48: 20-25. |
Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Penicaud L (2008) J. Acquir. Immune Defic. Syndr.
Abstract:
• O2k-Network Lab: FR_Toulouse_Casteilla L
Labels:
Regulation: Respiration; OXPHOS; ETS Capacity"Respiration; OXPHOS; ETS Capacity" is not in the list (Aerobic glycolysis, ADP, ATP, ATP production, AMP, Calcium, Coupling efficiency;uncoupling, Cyt c, Flux control, Inhibitor, ...) of allowed values for the "Respiration and regulation" property.
HRR: Oxygraph-2k
